Stay updated on TRx0237 in Mild Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the TRx0237 in Mild Alzheimer's Disease Clinical Trial page.

Latest updates to the TRx0237 in Mild Alzheimer's Disease Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2, reflecting a document version change. There are no visible changes to the study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check26 days agoChange DetectedThe funding status notice about government lapse has been removed from the page, a non-core site status element rather than the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check47 days agoChange DetectedNo significant data changes detected; the modifications appear limited to formatting and minor UI adjustments in the Study Details page, with location lists and core study information unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check69 days agoChange Detected- Added a prominent notice about potential outages due to funding and updated operating status references; updated version to v3.2.0. - Removed v3.1.0 declaration.SummaryDifference3%

- Check77 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, updating the page version identifier.SummaryDifference0.1%

- Check84 days agoChange DetectedRemoved explicit mentions of Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, and Substandard Drugs; overall content framing in the safety/quality area appears diminished.SummaryDifference0.3%

Stay in the know with updates to TRx0237 in Mild Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRx0237 in Mild Alzheimer's Disease Clinical Trial page.